Automated image acquisition

Automated image interpretation

Progression monitoring

CVD risk prediction


Can be deployed on-cloud or on-premises
On-device integration available
Standalone app available
Applications
POqUS can improve the efficiency and accuracy of various clinical use-cases such as post-stroke/TIA carotid screening, pre-surgery carotid screening to identify the risk of preoperative stroke (Ex: CABG), screening & treatment of asymptomatic individuals with atherosclerotic plaques, and clinical trials of drugs that manage/reverse atherosclerosis.

Automated detection of Carotid Artery Stenosis
Narrowing of the carotid artery is responsible for ∼20% of strokes in the adult population. POqUS detects and grades the degree of carotid artery stenosis as per international standards.
Automated detection and characterization of atherosclerotic plaques
- Plaque Buildup (Atherosclerosis) is the root cause of the narrowing of arteries. It results in the formation of blood clots and reduced blood flow to different parts of the body affecting the brain, heart, and limbs.
- POqUS auto-detects atherosclerotic plaques from B-mode images and characterizes the plaque by its appearance, texture, composition, size, etc. required for deciding the patient's treatment pathway.
AI-assisted acquisition of Diagnostic Quality Ultrasound Images
POqUS can reduce the turnaround time for acquiring carotid ultrasound images through AI-based guidance for probe navigation, anatomy detection, optimized ultrasound settings, auto-capture of diagnostic quality images, etc.
AI-generated carotid ultrasound reports
- Existing carotid ultrasound reports do not provide complete information for the management of patients with atherosclerotic plaques who could be either symptomatic or asymptomatic. Carotid reports differ significantly between different healthcare providers.
- POqUS provides editable AI-generated ultrasound reports that are more comprehensive, accurate, and standardized, with ~50% reduction in the time taken for interpreting carotid images.
Prevention of Cardiovascular diseases (CVD)
- Evidence suggests that certain types of plaques have a higher risk of CVD within ~3-6 months. For such plaques, medications such as sglt2 inhibitors, pcsk9 inhibitors, statins, and anti-platelets have demonstrated the ability to alter the plaque characteristics and prevent any critical event.
- POqUS helps identify asymptomatic patients with such plaque characteristics and estimates a dynamic CVD risk score that helps manage the patient's health with different treatment protocols.
Wide variations are observed in performing carotid duplex ultrasonography as well as interpretation of the findings. Introduction of automation, image guidance and AI are needed to improve the quality, reliability and reproducibility of this important diagnostic modality for evaluating and monitoring atherosclerotic disease.


Prof Vijay Sharma
Stroke Neurologist, Singapore

Dr. A.T. Prabhakar
Professor (Neurology); Christian Medical College, Vellore

Blog
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do tempor incididunt ut labore.